Cross-fund holdings
Stocks
Every stock held across the tracked funds' latest 13F filings, ranked by the number of funds holding it. Open a ticker or its highest-weight fund to continue the research trail.
| Ticker | Funds | Activity | Top fund weight | (OCF − SBC) / EV | Share reduction 1Y |
|---|---|---|---|---|---|
| AA Alcoa Corp. | 1 | ▼ −2 net | 0.11% (Gotham Ass…) | 15.6% Valuation basisOutstanding common shares; shares 2026-10-26; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-1.1% |
| AACG Ata Creativity Global | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-0.5% |
| AADX Applied Aerospace & Defense Inc - US | 1 | — | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. |
-94.7% |
| AAME Atlantic Amern Corp. | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2025-12-31; statement 2025-12-31. Price 2026-11-18. EV: missing current cash or debt. |
0% |
| AAMI Brightsphere Invt Group Inc. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-11-03; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
1.1% |
| AAP Advance Auto Parts Inc. | 1 | ▲ +1 net | 0.01% (Gotham Ass…) | 12.7% Valuation basisOutstanding common shares; shares 2026-10-10; statement 2026-10-10. Price 2026-11-18. TTM cash flow / current EV. |
0% |
| AAXJ Ishares TR | 1 | ▲ +1 net | 0.01% (Renaissanc…) | — | — |
| ABM ABM Inds Inc. | 1 | ▼ −1 net | 0% (Gotham Ass…) | 7.7% Valuation basisOutstanding common shares; shares 2026-07-31; statement 2026-07-31. Price 2026-11-18. TTM cash flow / current EV. |
5% |
| ABOS Acumen Pharmaceuticals Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: nonpositive ev. |
-19.4% |
| ABR Arbor Realty Trust Inc. | 1 | ▼ −1 net | 0.03% (Coatue Man…) | 2.9% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
4.7% |
| ABVX Abivax S.A. | 1 | ▼ −1 net | 0.01% (Tudor Inve…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-24% |
| ACA Arcosa Inc. | 1 | ▲ +1 net | 0.11% (Tudor Inve…) | 3.8% Valuation basisOutstanding common shares; shares 2026-07-15; statement 2026-06-30. Price 2026-10-22. TTM cash flow / current EV. |
-0.1% |
| ACB Aurora Cannabis Inc. | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-3.1% |
| ACCO ACCO Brands Corp. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | 10% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-2.4% |
| ACCS Access Newswire Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | 8.7% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
2.2% |
| ACDC ProFrac Holding Corp - US | 1 | ▲ +1 net | 0% (Tudor Inve…) | 9% Valuation basisOutstanding common shares; shares 2026-11-02; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-0.7% |
| ACET Adicet Bio Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-12.4% |
| ACIC American Coastal Ins Corp. | 1 | ▼ −2 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
3% |
| ACIU Ac Immune SA | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-1.3% |
| ACLS Axcelis Technologies Inc. | 1 | — | 0% (Gotham Ass…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
0.4% |
| ACMR Acm Research Inc - US | 1 | ▼ −2 net | 0.01% (Renaissanc…) | -4.1% EstimateEstimate using weighted-average diluted shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-7.6% |
| ACNB ACNB Corp. | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
2.5% |
| ACNT Ascent Industries Co. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
3.8% |
| ACOG Alpha Cognition Inc - US | 1 | — | 0% (Tudor Inve…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-35.3% |
| ACRS Aclaris Therapeutics Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-39.2% |
| ACRV Acrivon Therapeutics Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-06-30; statement 2026-06-30. Price 2026-11-18. EV: missing current cash or debt. |
-36.2% |
| ACTG Acacia Resh Corp. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | 20.3% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-1.2% |
| ACTU Actuate Therapeutics Inc. | 1 | ▲ +1 net | 0.08% (Voss Capit…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-6.5% |
| ACU Acme Utd Corp. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | 5.9% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-4.2% |
| ACVA Acv Auctions Inc. | 1 | ▼ −2 net | 0% (Tudor Inve…) | — Valuation basisOutstanding common shares; shares 2026-06-30; statement 2026-06-30. Price 2026-10-15. EV: missing current cash or debt. |
1.7% |
| ADAG Adagene | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-0.6% |
| ADCT ADC Therapeutics SA | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-13.4% |
| ADNT Adient Plc - US | 1 | ▼ −2 net | 0% (Gotham Ass…) | 19.1% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. FY 2026 cash flow / current EV. |
5.5% |
| ADV Advantage Solutions Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | 6.5% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
1.9% |
| AEBI AEBI Schmidt Holding AG | 1 | ▲ +1 net | 0% (Renaissanc…) | 2.2% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-0.4% |
| AEG Aegon Ltd - US NY Reg Shrs | 1 | — | 0% (Gotham Ass…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
4.7% |
| AEI Alset Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
0.5% |
| AEO American Eagle Outfitters In | 1 | ▼ −2 net | 0.02% (Tudor Inve…) | 15.7% Valuation basisOutstanding common shares; shares 2026-08-01; statement 2026-08-01. Price 2026-11-18. TTM cash flow / current EV. |
1% |
| AER Aercap Holdings NV | 1 | ▼ −2 net | 5.71% (Dorsey Ass…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
10.7% |
| AEYE Audioeye Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | 1.1% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-2.1% |
| AFCG Advanced Flower Cap Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
0.8% |
| AFRI Forafric Global PLC | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-0.1% |
| AGBK Agi Inc. | 1 | ▲ +1 net | 0% (Renaissanc…) | — | — |
| AGEN Agenus Inc. | 1 | ▲ +1 net | 0% (Renaissanc…) | -46.6% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-37.8% |
| AGM Federal Agricultural Mortgage Corp - US Class C | 1 | ▲ +1 net | 0.01% (Renaissanc…) | 2.5% EstimateEstimate using weighted-average diluted shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. OCF: TTM; FCF: FY 2025; OCF − SBC: TTM; FCF − SBC: FY 2025 cash flow / current EV. |
0.6% |
| AGYS Agilysys Inc - US | 1 | ▲ +1 net | 0% (Gotham Ass…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-0.6% |
| AHG Akso Health Group | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-31% |
| AHR American Healthcare REIT Inc - US | 1 | — | 0.01% (Gotham Ass…) | 2.8% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-30.8% |
| AHT Ashford Hospitality TR Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | 0.1% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-4.6% |
| AIA Ishares TR | 1 | ▲ +1 net | 0% (Renaissanc…) | — | — |
| AIFA All In Futuretech Alliance I | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-06-30; statement 2026-06-30. Price 2026-11-18. EV: missing current cash or debt. |
83.1% |
| AII American Integrity Ins Group | 1 | ▼ −1 net | 0% (Renaissanc…) | 89.2% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-0.1% |
| AIIR Air Global PLC | 1 | — | 9.48% (Conifer Ma…) | — | — |
| AIRG Airgain Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-10.7% |
| AIRO AIRO Group Holdings Inc - US | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-1.8% |
| AIRR First Trust RBA American Industrial Renaissance ET | 1 | ▼ −1 net | 0% (Gotham Ass…) | — | — |
| AIRT Air T Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
1.3% |
| AIV Apartment Invt & Management Co. -A | 1 | ▲ +1 net | 0% (Tudor Inve…) | — Valuation basisOutstanding common shares; shares 2026-03-31; statement 2026-03-31. Price 2026-11-18. EV: missing current cash or debt. |
-2.9% |
| AKA A K A Brands Holding Corp. | 1 | ▼ −1 net | 0% (Renaissanc…) | 7.9% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-3% |
| AKBA Akebia Therapeutics Inc. | 1 | — | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: nonpositive ev. |
-4.6% |
| AKO.A Embotelladora Andina S A | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-10-02. EV: missing economic mapping. |
0% |
| AKO.B Embotelladora Andina S A | 1 | ▼ −1 net | 0.02% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-16. EV: missing economic mapping. |
0% |
| AKR Acadia Realty Trust - US REIT | 1 | ▼ −1 net | 0% (Tudor Inve…) | 3.4% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-5.4% |
| ALAR Alarum Technologies Ltd. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-3.8% |
| ALDX Aldeyra Therapeutics, Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-0.3% |
| ALG Alamo Group Inc. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | 9.6% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-0.3% |
| ALGM Allegro MicroSystems Inc | 1 | ▲ +1 net | 0.03% (Gotham Ass…) | 1.6% Valuation basisOutstanding common shares; shares 2026-09-25; statement 2026-09-25. Price 2026-11-18. TTM cash flow / current EV. |
-0.7% |
| ALLO Allogene Therapeutics Inc. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-55.2% |
| ALLR Allarity Therapeutics Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-0.2% |
| ALMS Alumis | 1 | ▼ −1 net | 0% (Tudor Inve…) | — EstimateEstimate using weighted-average diluted shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-24.2% |
| ALNY Alnylam Pharmaceuticals, Inc. | 1 | ▲ +1 net | 0.07% (Gotham Ass…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-1.6% |
| ALRS Alerus Finl Corp. | 1 | ▼ −1 net | 0% (Renaissanc…) | 13.5% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
2.6% |
| ALVOW Alvotech SA | 1 | — | 0.01% (Oaktree Ca…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-09-28. EV: missing economic mapping. |
-3.4% |
| ALX Alexanders Inc. | 1 | ▼ −1 net | 0.01% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
0% |
| ALXO Alx Oncology Holdings Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | -67.1% Valuation basisOutstanding common shares; shares 2026-06-30; statement 2026-06-30. Price 2026-11-18. TTM cash flow / current EV. |
-158.3% |
| AMBP Ardagh Metal Packaging Sa - US | 1 | — | 0.02% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
0% |
| AMCR Amcor Plc - US | 1 | ▲ +1 net | 0.05% (Gotham Ass…) | 4.9% Valuation basisOutstanding common shares; shares 2026-11-03; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
80% |
| AMDL Graniteshares ETF TR | 1 | ▼ −1 net | 0% (Renaissanc…) | — | — |
| AMLX Amylyx Pharmaceuticals Inc. | 1 | — | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-17.1% |
| AMPY Amplify Energy Corp. | 1 | ▼ −1 net | 0% (Renaissanc…) | -6.2% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-0.7% |
| AMRC Ameresco Inc - US | 1 | ▼ −1 net | 0% (Tudor Inve…) | — EstimateEstimate using weighted-average diluted shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. |
-0.6% |
| AMRN Amarin Corp. PLC | 1 | ▼ −1 net | 0% (Renaissanc…) | 0.7% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-1.4% |
| AMRX Amneal Pharmaceuticals Inc. | 1 | — | 0% (Gotham Ass…) | 1.8% Valuation basisOutstanding common shares; shares 2026-07-31; statement 2026-06-30. Price 2026-11-18. TTM cash flow / current EV. |
-1.7% |
| AMRZ Amrize Ltd - US | 1 | ▼ −1 net | 0.05% (Renaissanc…) | 7.7% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
2.9% |
| AMS American Shared Hospital SVC | 1 | ▲ +1 net | 0% (Renaissanc…) | 27.8% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-2.2% |
| AMTD AMTD Idea Group | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-17. EV: missing economic mapping. |
— |
| AMWL American Well Corp. | 1 | ▲ +1 net | 0.01% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-5% |
| AMX America Movil Sab De CV | 1 | ▼ −1 net | 0.02% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
2.3% |
| ANGI ANGI Inc. | 1 | ▲ +1 net | 0% (Tudor Inve…) | — | — |
| ANGL Vaneck ETF Trust | 1 | — | 0% (Gotham Ass…) | — | — |
| ANGO Angiodynamics Inc - US | 1 | ▼ −2 net | 0.01% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-08-31; statement 2026-08-31. Price 2026-11-18. EV: missing current cash or debt. |
-2.4% |
| ANGX Angel Studios Inc - US | 1 | ▼ −2 net | 0.01% (Renaissanc…) | -1.7% Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-16.4% |
| ANIX Anixa Biosciences Inc. | 1 | ▲ +1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-07-31; statement 2026-07-31. Price 2026-11-18. EV: missing current cash or debt. |
-5.4% |
| ANL Adlai Nortye Ltd. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisValuation unavailable: missing economic mapping. Price 2026-11-18. EV: missing economic mapping. |
-121% |
| ANNX Annexon Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | -31% EstimateEstimate using weighted-average diluted shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-37.2% |
| ANTX An2 Therapeutics Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-38.4% |
| ANVS Annovis Bio Inc - US | 1 | ▼ −2 net | 0% (Renaissanc…) | — Valuation basisOutstanding common shares; shares 2026-09-30; statement 2026-09-30. Price 2026-11-18. EV: missing current cash or debt. |
-111.4% |
| AOK Ishares TR | 1 | ▲ +1 net | 0.03% (Thrive Cap…) | — | — |
| AOM Ishares TR | 1 | ▼ −1 net | 0.02% (Thrive Cap…) | — | — |
| AORT Artivion Inc. | 1 | ▼ −1 net | 0% (Renaissanc…) | -1% Valuation basisOutstanding common shares; shares 2026-10-30; statement 2026-09-30. Price 2026-11-18. TTM cash flow / current EV. |
-3% |
Showing 100 of 4,509 stocks
Load next 100 stocks